ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1285

Joint Injection Workflow in Rheumatology – an Opportunity to Improve Efficiency and Physician Satisfaction

Melissa Band1, Eric Newman2, Andrea Berger1, Kirsten Koons3, Madhuri Duggirala1, Rajesh Kuppuraju4, Peter Daniel Nicholas III5, David Bulbin6, David Pugliese7 and Jonida Cote8, 1Geisinger Medical Center, Danville, PA, 2Geisinger, Danville, PA, 3Geisinger Medical Center, Lewisburg, PA, 4Geisinger Medical Center, General Rheumatology Fellowship, Danville, PA, 5Geisinger Medical Center, Leesport, PA, 6Geisinger Health System, Danville, PA, 7Geisinger Health System, Wilkes-Barre, PA, 8Geisinger Medical Center, Orefield, PA

Meeting: ACR Convergence 2022

Keywords: Access to care, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Measures and Measurement of Healthcare Quality Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Physicians strive to provide patient-centered, timely care, often with perceived inadequate blocked time on the schedule. We aim to understand the joint injection workflow, its time allocation in the clinic, and physician satisfaction with the process in our academic rheumatology center.

Methods: An 11-question survey was used to gauge physicians’ perception of the injection workflow and time allocation with 88% responses achieved. This was compared to observed live-mapping of 50 injections 9/7/2021-1/11/2022 and chart review of 1076 injections 9/1/2020 – 8/31/2021 extracted from the electronic health record. Patient demographics, disease and injection type, and time blocked for the procedure on the physician’s schedule were obtained. Observed proportions from chart review were compared to hypothesized proportions based on median responses to questions 1-9 by 1-sample proportion-tests. The median procedure time from live observation was compared to the median value of physician perception in question 10 by Wilcoxon signed-rank test.

Results: Our population consisted of 72% women and 28% men, median age of 65 years old, mainly non-Hispanic, receiving recurrent injections for non-inflammatory joint disease. Only 20% of the procedures had scheduled injection time versus (vs) 80% who didn’t per chart review (Table 1). Live-mapping data showed 8% of injections had scheduled time, while 92% were done as part of a standard clinic visit without blocked time, exceeding the scheduled clinic time by a median of 17.7 minutes (Table 2). Table 3 compares physician perception to observed chart review (questions 1-4) and live mapping (questions 5-10) patient injections. Physicians perceived doing 30% new/70% recurrent injections vs observed 21.6%/78.4% injections respectively (p< 0.0001). They perceived doing 25% inflammatory/75% non-inflammatory injections vs observed 17%/83% respectively (p< 0.0001). The perceived median time spent on an injection was 20 minutes vs observed median time 18.8 minutes (p=0.071). Physicians had 100% completion of consents/orders/documentation by both perception and observation. Nurses were perceived to assist with patient preparation 33% of the time and injection preparation 27% of the time but were observed to assist 100% and 82% of the time respectively. 80% of physicians reported low satisfaction with the process. We multiplied the number of unscheduled injections (856) by the median observed injection time (18.8 minutes) and divided it by physician full time equivalent (FTE 8.9) for this study resulting in an estimated 30 unblocked hours/clinical FTE/year over templated time as a result of unscheduled procedures at the current injection efficiency.

Conclusion: Time constraint is a common barrier to patient centered care and physician satisfaction. In our academic rheumatology center, the joint injection process took 17-19 minutes/injection. In addition, 80% of injections were done unscheduled resulting in an additional 30 clinical hours per physician per year over templated clinic time. 80% of physicians were not satisfied with the current injection process. Based on this data, we are redesigning the injection workflow to improve efficiency and physician experience.

Supporting image 1

Table 1: Observational Chart Review Data of Injection Procedures

Supporting image 2

Table 2: Live Map Summary of Procedure Time in the Rheumatology Department

Supporting image 3

Table 3: Physician Perception Versus Observed Patient Data of the Joint Injection Workflow Process


Disclosures: M. Band, None; E. Newman, None; A. Berger, None; K. Koons, None; M. Duggirala, None; R. Kuppuraju, None; P. Nicholas III, None; D. Bulbin, AbbVie/Abbott, Novartis, Sanofi Genzyme, Alexion; D. Pugliese, None; J. Cote, None.

To cite this abstract in AMA style:

Band M, Newman E, Berger A, Koons K, Duggirala M, Kuppuraju R, Nicholas III P, Bulbin D, Pugliese D, Cote J. Joint Injection Workflow in Rheumatology – an Opportunity to Improve Efficiency and Physician Satisfaction [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/joint-injection-workflow-in-rheumatology-an-opportunity-to-improve-efficiency-and-physician-satisfaction/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/joint-injection-workflow-in-rheumatology-an-opportunity-to-improve-efficiency-and-physician-satisfaction/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology